Literature DB >> 1661643

Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins.

N Saha1, A C Roy, S H Teo, J S Tay, S S Ratnam.   

Abstract

One hundred and sixty-three healthy Chinese subjects of both sexes were studied for serum paraoxonase (PON) polymorphism, and levels of lipids and apolipoproteins in order to examine effects of PON alleles on these parameters. The level of serum triglyceride was significantly higher in high activity allele (PON*B) compared with that in low activity allele (PON*A) in both sexes (P less than 0.01). The subjects with PON A had significantly higher LDL cholesterol (P less than 0.05) and lower Apo A-II and ApoB levels. The influence of serum paraoxonase on serum lipids was estimated further by Spearman's rank correlation. In the males, there was a significant negative correlation of serum paraoxonase activity with total (P less than 0.05) and LDL (P less than 0.01) cholesterol levels, and positive correlation with HDL cholesterol and Apo A-II levels (P less than 0.05). Serum paraoxonase activity had a high positive correlation with serum triglyceride levels in both sexes (P less than 0.001). Serum ApoB level had a positive correlation with the enzyme activity only in females (P less than 0.01). The allelic effect of PON on these parameters was studied by multiple regression analysis. The high activity allele (PON*B) was associated with higher serum triglyceride level (P less than 0.001) and ApoB (P less than 0.001), while it had lowering influence on total cholesterol (P less than 0.05) and LDL cholesterol (P less than 0.005) in men. The average allelic effect of PON was found to be about 22% for serum triglycerides, 11% for LDL cholesterol, 14% for Apo A-II and 19% for Apo B in the present study. This study suggests a possible significant role of serum paraoxonase alleles in the metabolism of serum lipids and apolipoproteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661643     DOI: 10.1111/j.1399-0004.1991.tb03096.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  16 in total

1.  Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

Authors:  Luis M Moura; Susana Faria; Miguel Brito; Fausto J Pinto; Steen D Kristensen; Isabel M Barros; Nalini Rajamannan; Francisco Rocha-Gonçalves
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

2.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

Authors:  A D Watson; J A Berliner; S Y Hama; B N La Du; K F Faull; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

Authors:  M C Garin; R W James; P Dussoix; H Blanché; P Passa; P Froguel; J Ruiz
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

Authors:  L W Castellani; M Navab; B J Van Lenten; C C Hedrick; S Y Hama; A M Goto; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

5.  Paraoxonase 1 status in the Thai population.

Authors:  Wimon Phuntuwate; Chuthamanee Suthisisang; Banhan Koanantakul; Michael I Mackness; Bharti Mackness
Journal:  J Hum Genet       Date:  2005-05-28       Impact factor: 3.172

6.  Is alcohol beneficial or harmful for cardioprotection?

Authors:  Raj Lakshman; Mamatha Garige; Maokai Gong; Leslie Leckey; Ravi Varatharajalu; Samir Zakhari
Journal:  Genes Nutr       Date:  2010-06       Impact factor: 5.523

7.  Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population.

Authors:  Ufuk Cakatay; Refik Kayali; Hafize Uzun
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

8.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Authors:  M C Blatter Garin; C Abbott; S Messmer; M Mackness; P Durrington; D Pometta; R W James
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

9.  Determinants of variation in human serum paraoxonase activity.

Authors:  D L Rainwater; S Rutherford; T D Dyer; E D Rainwater; S A Cole; J L Vandeberg; L Almasy; J Blangero; J W Maccluer; M C Mahaney
Journal:  Heredity (Edinb)       Date:  2008-10-29       Impact factor: 3.821

10.  Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.

Authors:  D M Shih; L Gu; S Hama; Y R Xia; M Navab; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.